Lake Street Keeps Their Buy Rating on Achieve Life Sciences (ACHV)
I'm PortAI, I can summarize articles.
Lake Street analyst Thomas Flaten has reaffirmed a Buy rating on Achieve Life Sciences (ACHV) with a price target of $11.00. Flaten, a 5-star analyst with an 18.0% average return and a 54.15% success rate, focuses on the Healthcare sector. The current analyst consensus for Achieve Life Sciences is a Strong Buy, with an average price target of $14.60.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments